OBIO CAAP Company: ChipCare on the Business News Network's "The Disruptors"

ChipCare was featured on BNN's The Disruptors this past March. The focus of the interview was ChipCare's differentiation to Theranos, their Series B raise and product pipeline, and their initial focus on low and middle income countries as a smart market entry approach.

Click here for the full interview

Previous
Previous

OBIO brings Innovation in Action to Queen’s Park

Next
Next

Federal Budget Misses Opportunity to Scale and Grow Health Science Companies